Reyes Financial Architecture’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-51
Closed -$9.29K 360
2025
Q4
$9.29K Buy
+51
New +$8.95K 0.01% 253

Other funds holding AZN

Reyes Financial Architecture's AZN Position: Q1 2026 in Review

Reyes Financial Architecture sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 51 shares — an estimated $9.29K sold.

Reyes Financial Architecture first reported a position in AZN in Q4 2025 and held it in 1 quarter. The position peaked at $9.29K in Q4 2025. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Reyes Financial Architecture reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Reyes Financial Architecture sold 51 AstraZeneca shares in Q1 2026, an estimated $9.29K.
  • Reyes Financial Architecture first reported a position in AstraZeneca in Q4 2025 and held it in 1 quarter.
  • Reyes Financial Architecture's AstraZeneca position peaked at $9.29K in Q4 2025.
  • 1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Reyes Financial Architecture's 13F filing for Q1 2026, filed 12 May 2026.